BBOTVSSHFS• 3 Months (Normalized)
BBOT vs SHFS (BridgeBio Oncology Therapeutics Inc. vs SHF Holdings Inc.)
Showing Closing Date Range from Jul 4 to Oct 2, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
BBOT Performance $3.89
-53.75%
BridgeBio Oncology Therapeutics Inc.
Normalized Baseline0.00%
SHFS Performance $1.18
+400%
SHF Holdings Inc.
Normalized Baseline0.00%
Alpha Spread Margin SHFS LEADS
-453.75 pts
SHFS outperforming by 453.75 percentage points
BBOTSHFS
Spread Trajectory3 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
BBOT SHFS
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(63 dates)
| Date | BBOT Price | BBOT Gain (%) | SHFS Price | SHFS Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 02, 2026 | $3.89 | -53.75% | $1.18 | +400.00% | -453.75% |
| Sep 30, 2026 | $4.10 | -51.25% | $- | - | |
| Sep 29, 2026 | $3.92 | -53.39% | $- | - | |
| Sep 28, 2026 | $3.81 | -54.70% | $- | - | |
| Sep 25, 2026 | $3.95 | -53.03% | $0.16 | -33.39% | -19.64% |
| Sep 24, 2026 | $3.99 | -52.56% | $0.17 | -29.24% | -23.32% |
| Sep 23, 2026 | $4.16 | -50.54% | $0.17 | -29.66% | -20.88% |
| Sep 22, 2026 | $4.66 | -44.59% | $0.18 | -25.00% | -19.59% |
| Sep 21, 2026 | $4.66 | -44.59% | $0.16 | -31.78% | -12.81% |
| Sep 18, 2026 | $4.77 | -43.28% | $0.16 | -30.93% | -12.35% |
| Sep 17, 2026 | $4.89 | -41.85% | $0.17 | -26.69% | -15.16% |
| Sep 16, 2026 | $4.76 | -43.40% | $0.16 | -33.90% | -9.50% |
| Sep 15, 2026 | $4.88 | -41.97% | $0.15 | -38.56% | -3.41% |
| Sep 14, 2026 | $5.05 | -39.95% | $0.16 | -32.63% | -7.32% |
| Sep 11, 2026 | $4.95 | -41.14% | $0.15 | -34.75% | -6.39% |
Page 1 of 5